You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 2, February 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  News and Views
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients

Neal R. Swerdlow, MD, PhD; David L. Braff, MD; Navid Taaid; Mark A. Geyer, PhD
From the Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla.

Arch Gen Psychiatry. 1994;51(2):139-154.


Abstract

Psychiatric researchers need specific animal models to better understand the neurobiology of schizophrenia. Prepulse inhibition (PPI), the reduction in startle produced by a prepulse stimulus, is diminished in schizophrenic patients. Theoretically, deficient PPI in schizophrenic patients reflects a loss of sensorimotor gating that may lead to sensory flooding and cognitive fragmentation. In rats, PPI is disrupted by systemic administration of dopamine agonists or by manipulations of neural circuitry linking the limbic cortex, striatum, pallidum, and pontine reticular formation. This loss of PPI in rats may be a useful model for studying the neurobiology of impaired sensorimotor gating in schizophrenic patients. We assessed the face, predictive, and construct validity of this animal model. Face validity was supported: stimulus manipulations produced parallel changes in PPI in humans and rats, and the dopamine agonist apomorphine disrupted PPI in rats, mimicking PPI deficits in schizophrenics. Predictive validity was supported: the ability of antipsychotics to restore PPI in apomorphine-treated rats correlated with clinical antipsychotic potency (rs=.991) and D2-receptor affinity (rs=.893). Antipsychotics that restore PPI in apomorphine-treated rats include "typical" antipsychotics and the "atypical" antipsychotic clozapine. Construct validity was supported: PPI was disrupted in rats when dopamine was infused into the nucleus accumbens; this effect was blocked by haloperidol. The loss of PPI in dopamine-activated rats may be a valid animal model of sensorimotor gating deficits in schizophrenic patients. This model may help us understand the neurobiology of cognitive deficits in schizophrenic patients.




Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Labrie et al.
Hum Mol Genet 2009;18:3227-3243.
ABSTRACT | FULL TEXT  

Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS
Green et al.
Schizophr Bull 2009;35:163-181.
ABSTRACT | FULL TEXT  

Sensorimotor Gating of Schizophrenia Patients Depends on Catechol O-Methyltransferase Val158Met Polymorphism
Quednow et al.
Schizophr Bull 2008;0:sbn088v1-sbn088.
ABSTRACT | FULL TEXT  

Sensorimotor Gating in Larval Zebrafish
Burgess and Granato
J. Neurosci. 2007;27:4984-4994.
ABSTRACT | FULL TEXT  

({+/-}) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics
Cilia et al.
J Psychopharmacol 2007;21:302-311.
ABSTRACT  

A Neuropsychiatric Model of Biological and Psychological Processes in the Remission of Delusions and Auditory Hallucinations
van der Gaag
Schizophr Bull 2006;32:S113-S122.
ABSTRACT | FULL TEXT  

Pharmacologic Interactions between the Muscarinic Cholinergic and Dopaminergic Systems in the Modulation of Prepulse Inhibition in Rats
Jones et al.
J. Pharmacol. Exp. Ther. 2005;312:1055-1063.
ABSTRACT | FULL TEXT  

Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies
Aasen et al.
J Psychopharmacol 2005;19:39-45.
ABSTRACT  

Radiotelemetry comes of age--perhaps just in time
Printz
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R818-R819.
FULL TEXT  

Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study
Kumari et al.
J Psychopharmacol 2003;17:89-95.
ABSTRACT  

Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice
Ralph-Williams et al.
J. Neurosci. 2002;22:9604-9611.
ABSTRACT | FULL TEXT  

Neurotensin and Dopamine Interactions
Binder et al.
Pharmacol. Rev. 2001;53:453-486.
ABSTRACT | FULL TEXT  

The Muscarinic Receptor Agonist Xanomeline Has an Antipsychotic-Like Profile in the Rat
Stanhope et al.
J. Pharmacol. Exp. Ther. 2001;299:782-792.
ABSTRACT | FULL TEXT  

Effects of JL13, a Pyridobenzoxazepine with Potential Atypical Antipsychotic Activity, in Animal Models for Schizophrenia
Ellenbroek et al.
J. Pharmacol. Exp. Ther. 2001;298:386-391.
ABSTRACT | FULL TEXT  

Enhanced Neurotensin Neurotransmission Is Involved in the Clinically Relevant Behavioral Effects of Antipsychotic Drugs: Evidence from Animal Models of Sensorimotor Gating
Binder et al.
J. Neurosci. 2001;21:601-608.
ABSTRACT | FULL TEXT  

Reflex Excitability Regulates Prepulse Inhibition
Schicatano et al.
J. Neurosci. 2000;20:4240-4247.
ABSTRACT | FULL TEXT  

Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists
Swerdlow et al.
J. Neurosci. 2000;20:4325-4336.
ABSTRACT | FULL TEXT  

Connecting the "Dots" of Brain Dysfunction in Schizophrenia: What Does the Picture Look Like?
Braff
Arch Gen Psychiatry 1999;56:791-793.
FULL TEXT  

Normalization of Information Processing Deficits in Schizophrenia With Clozapine
Kumari et al.
Am. J. Psychiatry 1999;156:1046-1051.
ABSTRACT | FULL TEXT  

The Dopamine D2, but not D3 or D4, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice
Ralph et al.
J. Neurosci. 1999;19:4627-4633.
ABSTRACT | FULL TEXT  

Symptom Correlates of Prepulse Inhibition Deficits in Male Schizophrenic Patients
Braff et al.
Am. J. Psychiatry 1999;156:596-602.
ABSTRACT | FULL TEXT  

Sensorimotor Gating and Thought Disturbance Measured in Close Temporal Proximity in Schizophrenic Patients
Perry et al.
Arch Gen Psychiatry 1999;56:277-281.
ABSTRACT | FULL TEXT  

Novel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist
Feifel et al.
J. Pharmacol. Exp. Ther. 1999;288:710-713.
ABSTRACT | FULL TEXT  

Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Danysz and Parsons
Pharmacol. Rev. 1998;50:597-664.
ABSTRACT | FULL TEXT  

Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
Gogos et al.
Proc. Natl. Acad. Sci. USA 1998;95:9991-9996.
ABSTRACT | FULL TEXT  

Adrenergic alpha 2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
Sallinen et al.
J. Neurosci. 1998;18:3035-3042.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.